Reducing the glycan heterogeneity of recombinant proteins may improve the efficacy of biopharmaceuticals.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lepenies, B., Yin, J. & Seeberger, P.H. Curr. Opin. Chem. Biol. 14, 404–411 (2010).
Meuris, L. et al. Nat. Biotechnol. 32, 485–487 (2014).
Rich, J.R. & Withers, S.G. Nat. Chem. Biol. 5, 206–215 (2009).
Schwarz, F. et al. Nat. Chem. Biol. 6, 264–266 (2010).
Hamilton, S.R. et al. Science 313, 1441–1443 (2006).
Castilho, A. et al. Glycobiology 21, 813–823 (2011).
Aumiller, J.J., Mabashi-Asazuma, H., Hillar, A., Shi, X. & Jarvis, D.L. Glycobiology 22, 417–428 (2012).
Wang, Z. et al. Science 341, 379–383 (2013).
Wang, P. et al. Science 342, 1357–1360 (2013).
Seeberger, P.H. & Werz, D.B. Nature 446, 1046–1051 (2007).
Reeves, P.J., Callewaert, N., Contreras, R. & Khorana, H.G. Proc. Natl. Acad. Sci. USA 99, 13419–13424 (2002).
Lepenies, B., Lee, J. & Sonkaria, S. Adv. Drug Deliv. Rev. 65, 1271–1281 (2013).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Lepenies, B., Seeberger, P. Simply better glycoproteins. Nat Biotechnol 32, 443–445 (2014). https://doi.org/10.1038/nbt.2893
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2893